Actos and Bladder Cancer
Actos, also called pioglitazone, is often prescribed to help control blood sugar levels in patients with Type II diabetes. In addition, Actos is used as a preventative diabetic medication for people showing early signs of diabetes. As one of the drug manufacturer Takeda’s biggest selling drugs, Actos earns the company billions of dollars each year.
In June of 2011, the Food and Drug Administration issued a safety warning that linked Actos to increased risk of bladder cancer, particularly in situations where Actos is taken for more than one year. This warning stemmed from a 10-year study whose preliminary results showed that the longer a patient took Actos, or the larger the dose taken, the greater the risk of bladder cancer. In people taking Actor for more than one year, the risk of bladder cancer increased 40 percent. Women taking Actos are five times as likely to suffer bladder cancer as women who do not take the drug. This, despite the fact that men have the greatest risk of developing bladder cancer.
Regulators in Europe have already suspended sales and use of Actos. Use of the drug in France and Germany was banned by authorities following another study that confirmed taking Actos raises the risk of bladder cancer. This study involved more than 150,000 subjects with diabetes. Patients who use Actos, or the diabetes drug Competact, must now use different medications.
Similar steps have not been taken in the United States. Actos is still being sold. However, regulators have mandated that additional information must be included on the drug’s label alerting users about the greater risk of bladder cancer. Medical experts and lawmakers alike have urged the Food and Drug Administration to remove Actos from the market, fearing that a simple black box warning will not provide adequate protection. In addition, medical experts and lawmakers claim the FDA did not adequately alert Actos users to certain cardiovascular risks associated with taking the drug.
Actos-related Bladder Cancer Symptoms and Side Effects
Some of the symptoms of bladder cancer related to Actos are blood in the urine, an infection in the urinary tract, an inability to urinate, pain while urinating, and frequent urination. Side effects associated with the use of Actos may include congestive heart failure, heart disease, liver problems, kidney cancer, and bone fracture.
If you or someone you love has taken Actos and been diagnosed with bladder cancer, or has encountered the dangerous side effects mentioned above, you should contact Hasbrook & Hasbrook – Oklahoma Drug Recall attorneys as soon as possible for a free consultation to discuss your situation. We can explain your options and help you obtain compensation for such things as lost income, lost enjoyment of life, pain and suffering, medical expenses, and more. You owe it to yourself and your family to seek compensation. Contact us today.
To learn more about Actos and to learn more about your legal rights, if you or a loved one have used Actos and have been diagnosed with bladder cancer, see: Actos Linked to Bladder Cancer.